Clinical trial
To Study And Compare Bioavailability And Safety Of Four Different Formulations…
NCT00436228 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00436228 |
|---|---|
| Title | To Study And Compare Bioavailability And Safety Of Four Different Formulations Of The Study Drug |
| Official title | An Open-Label, Randomized, Crossover Study to Estimate the Formulation Effect on the Relative Bioavailability of Single Dose Oral SB-742510 in Healthy Subjects |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Healthy Subjects |
| Enrollment | 32 |
| Start date | Nov 1, 2006 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Feb 19, 2007 |
| Last update posted | Oct 13, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: